International Medical Device Distribution

    Medical Device Distributor — International Distribution for CE, UKCA, and FDA-Cleared Devices

    TRADER PARTNERS LTD is an international medical device distributor handling Class I, II, and III devices through OEM-authorised channels. We deliver CE, UKCA, and FDA-cleared devices to hospitals, clinics, regional distributors, and public-sector buyers with the applicable regulatory documentation and worldwide logistics.

    Worker with a tablet scanning a barcoded sterile package in a clean medical device distribution warehouse
    OEM-authorised distribution, lot-level traceability, worldwide delivery.

    Capabilities

    What this service covers

    Verified Supply Channels

    Manufacturer-direct and OEM-authorised routes, with the supply channel verified and documented for each order.

    Class I, IIa, IIb, III Devices

    Distribution across all CE / FDA risk classes — surgical, cardiology, orthopaedics, urology, ENT, diagnostics, and more.

    Regulatory Documentation

    Declarations of conformity, CE / UKCA / FDA evidence, ISO 13485 certificates, IFU and labelling in destination language.

    Lot & Serial Traceability

    Lot-level traceability for single-use devices and serial-level traceability for capital devices, archived for warranty period.

    Cold-Chain Capable Logistics

    Temperature-controlled distribution for thermolabile reagents, biologics, and selected sterile devices.

    Recall & Field-Action Management

    48-hour propagation of manufacturer field-safety notices to all in-channel recipients of affected lots.

    Chapter 01

    Executive overview

    A medical device distributor sits in a regulated position between the device manufacturer and the clinical end-user. The distributor is responsible for preserving the manufacturer's regulatory state through transport and storage, for delivering the device with valid labelling and IFU, for maintaining traceability records, and for propagating field-safety notices when the manufacturer issues them. None of that is optional under CE, UKCA, or FDA regulatory regimes.

    TRADER PARTNERS LTD operates as a fully compliant international medical device distributor with UK registration (Companies House 16575073), documented quality management, and authorised channel distribution agreements with multiple manufacturers. We distribute to hospitals, clinics, laboratories, regional distributors, ministries of health, and humanitarian buyers worldwide.

    Chapter 02

    Service introduction — what a compliant distributor delivers

    Compliant medical device distribution is more than logistics. It requires a documented quality management system, controlled storage conditions, validated transport, lot-level traceability, and a defined field-safety notice procedure. Our distribution operation runs on an ISO 13485-aligned QMS covering device receipt, storage, picking, packing, dispatch, and post-market surveillance.

    For each medical device we distribute, we maintain a device file containing the manufacturer's regulatory documentation, the destination-market registration evidence, the labelling and IFU in the destination language, and the lot or serial register tied to each shipment. The device file is auditable on request by the buyer's quality team or by the destination regulator.

    Chapter 03

    Industry challenges in medical device distribution

    Buyers sourcing medical devices through international distribution channels face challenges that are largely invisible at the point of purchase but become visible at the customs gate, in the post-market surveillance audit, or during a manufacturer field-safety notice.

    • Grey-market exposure: devices sourced through unauthorised channels lose manufacturer warranty and can trigger regulatory non-compliance.
    • Incomplete regulatory packs: devices delivered without the destination-market labelling, without translated IFU, or without valid Declaration of Conformity.
    • Broken traceability: manufacturers cannot trace devices to end-users when the distribution chain has changed hands twice without recording.
    • Field-action exposure: end-users not notified of safety recalls because the distribution chain did not propagate the notice.
    • Cold-chain failures: thermolabile devices and reagents arriving with no temperature record, forcing precautionary release decisions.

    Chapter 04

    How TRADER PARTNERS LTD solves these challenges

    Grey-market exposure is removed by sourcing only through OEM-authorised channels — direct agreement with the manufacturer, or via the manufacturer's nominated regional distributor. Incomplete regulatory packs are prevented by our device file process: no shipment is released without the documentation pack verified against the destination-market requirement. Broken traceability is prevented by lot- and serial-level recording at receipt and dispatch, archived for the warranty period.

    Field-action exposure is managed by our post-market surveillance procedure: when a manufacturer issues a field-safety notice we propagate it to every recipient of affected lots within 48 hours of notice receipt, with documented confirmation back to the manufacturer. Cold-chain failures are prevented by validated transport packaging, continuous temperature monitoring, and a documented excursion-review procedure that holds product until release is signed off.

    Chapter 05

    Distribution process

    Each distribution engagement follows a documented process. Onboarding: confirmation of the buyer's regulatory destination, importer of record status, and clinical use case. Quotation: line-item pricing with applicable Incoterm, lead time, and documentation pack defined. Order placement: purchase order against quotation, with lot or serial pre-allocation where applicable. Production / pull from stock: device pull from OEM or distributor stock, with regulatory pack assembly.

    Pre-shipment QC: documentation pack verification, packaging inspection, and (for cold-chain) packaging validation. Dispatch: export documentation, freight booking under the agreed Incoterm. Transit monitoring: temperature monitoring for cold-chain, status reporting for capital devices. Delivery and acceptance: signed acceptance with lot or serial register confirmed. Post-delivery: warranty registration with OEM, field-safety notice channel established.

    • OEM-authorised channel verification on every device line
    • Device file maintained per device, per destination market
    • Lot- and serial-level traceability, archived for warranty period
    • 48-hour propagation of manufacturer field-safety notices
    • Cold-chain monitoring with documented excursion-review procedure

    Chapter 06

    Our manufacturer network

    We source branded devices through manufacturer-direct routes and OEM-authorised regional distributors, and we confirm the supply route in writing for each order before it is placed. Hologic-branded systems are one of the portfolios buyers ask us for most often — see the Hologic page for the range we source (ThinPrep, FFN, Panther / Panther Fusion molecular platforms, Aptima assays, breast health, skeletal health). The same channel-verification discipline applies across the rest of our supplier base, from European cardiology OEMs to Japanese endoscopy manufacturers and US-based orthopaedic specialists.

    For high-volume single-use devices (syringes, IV sets, wound care, surgical packs) we work with ISO 13485-certified manufacturers in Europe, India, and China, qualified under our Supplier Verification Process.

    Chapter 07

    Supplier verification for distributed devices

    Every manufacturer in our distribution network is qualified under our documented Supplier Verification Process. For medical device manufacturers specifically, qualification includes verification of CE / UKCA / FDA registrations, ISO 13485 status with last regulatory inspection outcome, post-market surveillance procedures, complaint and recall history, and the manufacturer's distribution authorisation (the document confirming we are an authorised channel for the relevant geography).

    Re-qualification is annual. Where a manufacturer's regulatory status changes (e.g. an FDA warning letter, a CE certificate suspension), we suspend new orders until the status is resolved and re-verified.

    Chapter 08

    Quality assurance for device distribution

    Our distribution QMS is aligned with ISO 13485 principles for medical device storage and distribution. Storage areas are temperature- and humidity-controlled, monitored continuously, and validated against the storage conditions stated on the manufacturer's labelling. Pick and pack operations are barcode-controlled with two-person verification on high-risk lines. Outbound shipments carry a quality release record signed by named QA staff.

    Returns, complaints, and non-conformities are logged in our complaint-handling system, investigated with the manufacturer where required, and reported to the destination-market regulator where mandatory under post-market surveillance rules.

    Chapter 09

    Regulatory compliance across distribution markets

    For each destination market we confirm the applicable medical device regulatory regime and the documentation required at customs and at the end-user. EU and UK: CE marking or UKCA marking, Declaration of Conformity, Authorised Representative details, labelling and IFU in the destination language. USA: FDA registration and listing, 510(k) or PMA evidence as applicable, US Agent details. Middle East: SFDA, MOH UAE, MOH Qatar, MOH Kuwait, MOH Oman registration evidence with destination-language labelling.

    Africa: NAFDAC, PPB Kenya, EDA Egypt, SAHPRA registration evidence with shipment manifests. Asia: CDSCO India, MFDS Korea, NMPA China, BPOM Indonesia, FDA Philippines, ANVISA Brazil — each handled per its specific dossier requirement.

    Chapter 10

    International logistics and export support

    We distribute under the full Incoterm range. For cold-chain devices we use validated packaging (active or passive) with continuous temperature monitoring and a documented excursion review on receipt. For dangerous goods (selected reagents, lithium batteries in some monitoring devices) we handle IATA and IMDG declarations and use DG-certified forwarders. For letter-of-credit transactions we prepare and present documentation directly to the negotiating bank.

    Lead times are confirmed at quotation: stock devices typically 1–3 weeks from order, make-to-order devices 4–16 weeks depending on manufacturer, with weekly status updates for orders over a confirmed value threshold.

    Chapter 11

    Distributed device categories

    Our distribution portfolio spans the major medical device categories, with depth in selected specialty areas through direct authorised channels.

    • Surgical: instruments, energy devices, endoscopy stacks, surgical implants
    • Cardiology: stents, catheters, electrophysiology, cardiac monitoring
    • Orthopaedics: implants, fixation, arthroscopy, joint reconstruction
    • Urology and gynaecology: catheters, lithotripsy, women's health diagnostics
    • ENT and ophthalmology: scopes, surgical instruments, diagnostic devices
    • Diagnostic platforms: chemistry, immunoassay, hematology, molecular (Hologic Panther / Aptima)
    • Imaging: mammography (2D / 3D), ultrasound, bone densitometry, mobile X-ray
    • Single-use consumables: syringes, IV sets, wound care, surgical packs
    • Reagents and IVD consumables on cold-chain logistics where required

    Chapter 12

    How buyers evaluate medical device distribution companies

    Buyers comparing medical device distribution companies — whether UK medical device distributors, regional distributors of medical devices, or international channels — are really comparing four things: whether the channel is OEM-authorised, whether the regulatory pack matches the destination market, whether traceability survives the handover, and whether field-safety notices actually reach the end-user. Price differences between distributors are usually smaller than the cost of getting any one of those four wrong.

    We publish our position on each. Channel: OEM-authorised only, verified per device line. Documentation: destination-market regulatory pack assembled and checked before release. Traceability: lot and serial recorded at receipt and dispatch, archived for the warranty period. Field actions: manufacturer notices propagated to every recipient of affected lots within 48 hours, with confirmation back to the manufacturer.

    • OEM and OEM-authorised channels only — no grey-market intermediaries
    • Destination-market documentation verified before dispatch, not after
    • Lot- and serial-level traceability retained for the warranty period
    • 48-hour field-safety notice propagation with documented confirmation
    • Distribution to hospitals, clinics, laboratories, and regional distributors alike

    Reach

    Regions We Serve

    Global medical procurement and supply network: sourcing regions across the United Kingdom, Europe, North America, the Middle East, Asia and Australia connected by international logistics routes.
    United KingdomEuropeMiddle EastAfricaAsiaNorth America
    UK Company No. 16575073
    13 Ashbourne Parade, London W5 3QS
    Supplier & product documentation verified per order

    Buyer questions

    Frequently Asked Questions

    Request a Quote from TRADER PARTNERS LTD

    UK-registered (Company No. 16575073). Worldwide sourcing, verified suppliers, full compliance documentation. Tell us what you need and our team will respond within one business day.